The results showed that overexpression of SPTBN1 significantly suppresses the development of primary osteoporosis by modulating VEGF, TGF-β/Smad3, and STAT1/Cxcl9 signaling pathways. The gene discussed is SMAD3; the disease is osteoporosis.